Rouquette M - Search Results

1

Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

Sobot D, Mura S, Rouquette M, Vukosavljevic B, Cayre F, Buchy E, Pieters G, Garcia-Argote S, Windbergs M, Desmaële D, Couvreur P. Sobot D, et al. Among authors: rouquette m. Mol Ther. 2017 Jul 5;25(7):1596-1605. doi: 10.1016/j.ymthe.2017.05.016. Epub 2017 Jun 9. Mol Ther. 2017. PMID: 28606375 Free PMC article.

2

Squalene-Adenosine Nanoparticles: Ligands of Adenosine Receptors or Adenosine Prodrug?

Rouquette M, Lepetre-Mouelhi S, Dufrançais O, Yang X, Mougin J, Pieters G, Garcia-Argote S, IJzerman AP, Couvreur P. Rouquette M, et al. J Pharmacol Exp Ther. 2019 Apr;369(1):144-151. doi: 10.1124/jpet.118.254961. Epub 2019 Jan 22. J Pharmacol Exp Ther. 2019. PMID: 30670479

3

Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles.

Dormont F, Rouquette M, Mahatsekake C, Gobeaux F, Peramo A, Brusini R, Calet S, Testard F, Lepetre-Mouelhi S, Desmaële D, Varna M, Couvreur P. Dormont F, et al. Among authors: rouquette m. J Control Release. 2019 Aug 10;307:302-314. doi: 10.1016/j.jconrel.2019.06.040. Epub 2019 Jun 29. J Control Release. 2019. PMID: 31260754 Free article.

4

Adenosine and lipids: A forced marriage or a love match?

Rouquette M, Lepetre-Mouelhi S, Couvreur P. Rouquette M, et al. Adv Drug Deliv Rev. 2019 Nov-Dec;151-152:233-244. doi: 10.1016/j.addr.2019.02.005. Epub 2019 Feb 21. Adv Drug Deliv Rev. 2019. PMID: 30797954 Review.

5

Albumin-driven disassembly of lipidic nanoparticles: the specific case of the squalene-adenosine nanodrug.

Gobeaux F, Bizeau J, Samson F, Marichal L, Grillo I, Wien F, Yesylevsky SO, Ramseyer C, Rouquette M, Lepêtre-Mouelhi S, Desmaële D, Couvreur P, Guenoun P, Renault JP, Testard F. Gobeaux F, et al. Among authors: rouquette m. Nanoscale. 2020 Jan 28;12(4):2793-2809. doi: 10.1039/c9nr06485k. Epub 2020 Jan 21. Nanoscale. 2020. PMID: 31961354

6

Towards a clinical application of freeze-dried squalene-based nanomedicines.

Rouquette M, Ser-Le Roux K, Polrot M, Bourgaux C, Michel JP, Testard F, Gobeaux F, Lepetre-Mouelhi S. Rouquette M, et al. J Drug Target. 2019 Jun-Jul;27(5-6):699-708. doi: 10.1080/1061186X.2019.1566340. Epub 2019 Feb 21. J Drug Target. 2019. PMID: 30786788

7

CL22 - a novel cationic peptide for efficient transfection of mammalian cells.

Haines AM, Irvine AS, Mountain A, Charlesworth J, Farrow NA, Husain RD, Hyde H, Ketteringham H, McDermott RH, Mulcahy AF, Mustoe TL, Reid SC, Rouquette M, Shaw JC, Thatcher DR, Welsh JH, Williams DE, Zauner W, Phillips RO. Haines AM, et al. Among authors: rouquette m. Gene Ther. 2001 Jan;8(2):99-110. doi: 10.1038/sj.gt.3301314. Gene Ther. 2001. PMID: 11313779

8

Xanthine oxidoreductase is asymmetrically localised on the outer surface of human endothelial and epithelial cells in culture.

Rouquette M, Page S, Bryant R, Benboubetra M, Stevens CR, Blake DR, Whish WD, Harrison R, Tosh D. Rouquette M, et al. FEBS Lett. 1998 Apr 24;426(3):397-401. doi: 10.1016/s0014-5793(98)00385-8. FEBS Lett. 1998. PMID: 9600274 Free article.

9

[The notion of variability in the experimental cadre].

Rouquette ML. Rouquette ML. Rech Soins Infirm. 1997 Sep;(50):55-9. Rech Soins Infirm. 1997. PMID: 9370739 French. No abstract available.

10

Expression of xanthine oxidase activity in human endothelial cells as a function of cell density.

Rouquette M, Stevens C, Blake DR, Harrison R, Whish J, Whish WD. Rouquette M, et al. Biochem Soc Trans. 1997 Aug;25(3):532S. doi: 10.1042/bst025532s. Biochem Soc Trans. 1997. PMID: 9388748 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page